ImmuniWeb® Continuous Penetration Testing vs Rapid7 Metasploit: Side-by-Side Comparison (2026)
Features, pricing, ratings, and pros & cons — compared head-to-head.
ImmuniWeb® Continuous Penetration Testing is a commercial penetration testing tool by ImmuniWeb. Rapid7 Metasploit is a commercial penetration testing tool by Rapid7. Compare features, ratings, integrations, and community reviews side by side to find the best penetration testing fit for your security stack.
CST VerdictBased on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
ImmuniWeb® Continuous Penetration Testing
Security teams managing APIs and web applications with frequent code deployments will get the most from ImmuniWeb® Continuous Penetration Testing because it re-scans automatically after changes rather than waiting for quarterly assessments. The service covers NIST ID.RA and PR.PS effectively, meaning it maps both your risk posture and platform vulnerabilities into a continuous cycle. Skip this if your organization needs penetration testing bundled with incident response or threat hunting; ImmuniWeb stays narrowly focused on finding what changed and what broke, not on detecting active compromise.
